Noncardiac surgery and the risk of death and other cardiovascular events in patients with hypertrophic cardiomyopathy

Clinical Cardiology

Volumn 29, Issue 2, 2006, Pages 65-68

  Hreybe, Haitham ^a   Zahid, Maliha ^a   Sonel, Ali ^b   Good, Chester B ^b   Shaver, James ^a   Saba, Samir ^a,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Death; Hypertrophic cardiomyopathy; Myocardial infarction; Noncardiac surgery

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; ELECTIVE SURGERY; EVALUATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERIOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RISK ASSESSMENT; RISK FACTOR; SURGICAL MORTALITY; UNITED STATES;

EID: 32544449975     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960290206     Document Type: Article

References (10)

1. Nishimura RA, Holmes DR Jr: Hypertrophic obstructive cardiomyopathy, N Engl J Med 2004;350:1320-1327
2. Maron BJ, Chaitman BR, Ackerman MJ, Bayés de Luna A, Corrado D, Crosson JE, Deal BJ, Driscoll DJ, Mark Estes NA III, Araújo CGS, Liang DH, Mitten MJ, Myerburg RJ, Pelliccia A, Thompson PD, Towbin JA, Van Camp SP, for the Working Groups of the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention; Councils on Clinical Cardiology and Cardiovascular Disease in the Young: Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004;109: 2807-2816
3. Maron BJ: Hypertrophic cardiomyopathy: A systematic review. J Am Med Assoc 2002;287:1308-1320
4. McKenna WJ, Mogensen J, Elliott PM: Role of genotyping in risk factor assessment for sudden death in hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;39:2042-2048
5. Fananapazir L, Chang AC, Epstein SE, McAreavey D: Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation 1992;86:730-740
6. Fananapazir L, Tracy CM, Leon MB, Winkler JB, Cannon RO III, Bonow RO, Maron BJ, Epstein SE: Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy: A consecutive analysis in 155 patients, Circulation 1989;80:1259-1268
7. Kuroiwa M, Arai M, Ueno T, Takenaka T, Okamoto H, Hoka S: Perioperative cardiovascular complications in patients with hypertrophic cardiomyopathy. Masui 2003;52:733-739
8. Haering JM, Comunale ME, Parker RA, Lowenstein E, Douglas PS, Krumholz HM, Manning WJ: Cardiac risk of noncardiac surgery in patients with asymmetric septal hypertrophy. Anesthesiology. 1996;85:254-259
9. Chang KH, Sano E, Saitoh Y, Hanaoka K: Anesthetic management of patients with hypertrophic obstructive cardiomyopathy undergoing non-cardiac surgery. Masui 2004;53:934-942
10. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froelich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL Jr: ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002;39:542-553